FFR-Guided PCI Offers Cost-Effective Benefit Compared with Medical Therapy Alone

Summary

A cost-effectiveness analysis of the Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Therapy (OMT) Versus OMT [FAME 2] trial indicates that FFR-guided PCI is economically viable. The initial cost of FFR-guided PCI is higher than that of medical therapy, but the cost gap narrows by >50% at 1 year.

  • Cardiology Clinical Trials
  • Interventional Techniques & Devices
  • Coronary Artery Disease
View Full Text
Back to top

Tools

View Full Page PDF
Citation Tools
Email
FFR-Guided PCI Offers Cost-Effective Benefit Compared with Medical Therapy Alone
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Cardiology Clinical Trials
Interventional Techniques & Devices
Coronary Artery Disease